Lipocine to present at the h.c. wainwright annual nash investor conference

Salt lake city , oct. 23, 2023 /prnewswire/ -- lipocine inc. (nasdaq: lpcn), a biopharmaceutical company focused on treating central nervous system (cns) disorders, today announced that it will present and meet with investors at the h.c. wainwright 7th annual nash investor conference, taking place virtually october 24, 2023.
LPCN Ratings Summary
LPCN Quant Ranking